Francisco Reyes-Madrigal

Author

Instituto Nacional de Neurología y Neurocirugía ORCID

Also Known As

Francisco Reyes-Madrigal, Paul E. Rasser, Servicio de Cuidados Paliativos, Instituto Nacional de Cancerología, Ciudad de México, México.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Neurología y Neurocirugía Centre for Addiction and Mental Health Universidad Fray Luca Paccioli King's College London University of Toronto

About

Francisco Reyes-Madrigal is an author at Instituto Nacional de Neurología y Neurocirugía specializing in psychiatry, schizophrenia, and biological psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	307
2	Social Sciences	9	9	280
3	Neuroscience	8	8	240
4	Neurology	7	7	163
5	Immunology	1	1	27

Francisco Reyes-Madrigal

Publications

694

Citations

H-Index

Page 1

	Year	Citations
Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction Eric Plitman, Camilo de la Fuente‐Sandoval, Francisco Reyes-Madrigal, Schizophrenia Bulletin	2015	97
Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy Camilo de la Fuente‐Sandoval, Francisco Reyes-Madrigal, Xiangling Mao, The International Journal of Neuropsychopharmacology	2015	90
Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients Camilo de la Fuente‐Sandoval, Francisco Reyes-Madrigal, Xiangling Mao, Biological Psychiatry PsychopathologyAntipsychotic TreatmentPsychiatryPsychotic DisorderPsychotropic Medication	2017	77
Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity Eric Plitman, Raihaan Patel, Jun Ku Chung, Neuropsychopharmacology Glutamatergic MetabolitesPsychoactive DrugPsychiatryNeurophysiologyPsychotropic Medication	2016	56
Frequency drift in MR spectroscopy at 3T Steve C. N. Hui, Mark E. Mikkelsen, Helge J. Zöllner, NeuroImage	2021	47
Personality features in ultra-high risk for psychosis: A comparative study with schizophrenia and control subjects using the Temperament and Character Inventory-Revised (TCI-R) Ana Fresán, Pablo León-Ortíz, Rebeca Robles, Journal of Psychiatric Research Personality PsychologyPersonality FeaturesPsychiatryRisk PredictionPsychotic Disorder	2014	40
Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis Helen Baldwin, Joaquim Raduà, Mathilde Antoniades, Translational Psychiatry	2022	37
Abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis Patricia Alvarado-Alanis, Pablo León-Ortíz, Francisco Reyes-Madrigal, Schizophrenia Research PsychiatryPsychotic DisorderWhite MatterSchizophreniaNeuroimaging	2015	35
Effects of socioeconomic status in cognition of people with schizophrenia: results from a Latin American collaboration network with 1175 subjects Letícia Sanguinetti Czepielewski, Luz María Alliende, Carmen Paz Castañeda, Psychological Medicine	2021	34
Cognitive Impairment in Never-Medicated Individuals on the Schizophrenia Spectrum Rodolfo Solís‐Vivanco, Felipe Rangel-Hassey, Pablo León-Ortíz, JAMA Psychiatry	2020	28

Page 1